Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial Response”

218 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 218 results

Not applicableNot Yet RecruitingNCT07410715
What this trial is testing

Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)

Who this might be right for
HCC - Hepatocellular CarcinomaWatch & WaitSurgery
West China Hospital 100
Early research (Phase 1)Study completedNCT05491785
What this trial is testing

Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.

Who this might be right for
Pain
Tris Pharma, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT04601831
What this trial is testing

'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL

Who this might be right for
Non-Hodgkin Lymphoma
University of Texas Southwestern Medical Center 14
Large-scale testing (Phase 3)Active Not RecruitingNCT01844986
What this trial is testing

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Who this might be right for
Newly DiagnosedAdvanced Ovarian CancerFIGO Stage III-IV+4 more
AstraZeneca 450
Not applicableLooking for participantsNCT06272799
What this trial is testing

Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.

Who this might be right for
Breast Cancer
Regina Elena Cancer Institute 160
Testing effectiveness (Phase 2)Study completedNCT00374244
What this trial is testing

Efficacy of Pimozide Augmentation for Clozapine Partial Response

Who this might be right for
Schizophrenia
Yale University 28
Early research (Phase 1)Ended earlyNCT01068145
What this trial is testing

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Study completedNCT01221675
What this trial is testing

TF2- Small Cell Lung Cancer Radio Immunotherapy

Who this might be right for
Small Cell Lung CancerCEA-expressing Non Small Cell Lung Carcinoma (NSCLC)
Centre René Gauducheau 18
Testing effectiveness (Phase 2)Study completedNCT00068107
What this trial is testing

Dosing Study of Replagal in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Baylor Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT00995800
What this trial is testing

Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma

Who this might be right for
Asthma
Mundipharma Research Limited 46
Not applicableUnknownNCT02437682
What this trial is testing

Translation and Validation of the PASS Test for GERD Patients With Partial Response to PPI: PASS-HK

Who this might be right for
Gastro-esophageal Reflux Disease
Chinese University of Hong Kong 100
Not applicableApproved For MarketingNCT03079687
What this trial is testing

Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Who this might be right for
Ovarian Cancer
AstraZeneca
Not applicableNot Yet RecruitingNCT07275138
What this trial is testing

Acute Cardiovascular and Neuromuscular Responses to Walking With Blood Flow Restriction (BFR) in Older Adults

Who this might be right for
Healthy Older Adults
Universidade da Coruña 20
Large-scale testing (Phase 3)Looking for participantsNCT07328854
What this trial is testing

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ming-Yuan Chen 346
Not applicableLooking for participantsNCT05652673
What this trial is testing

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Who this might be right for
Melanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more
Erasmus Medical Center 80
Not applicableStudy completedNCT06417203
What this trial is testing

Hypobaric Spinal or Hyperbaric in Partial Hip Arthroplasty

Who this might be right for
Post Operative Pain
Adiyaman University Research Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06175000
What this trial is testing

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Who this might be right for
Primary Central Nervous System Lymphoma
Providence Health & Services 28
Not applicableActive Not RecruitingNCT06640478
What this trial is testing

A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)

Who this might be right for
Type 1 Diabetes
Milton S. Hershey Medical Center 20
Not applicableStudy completedNCT06269822
What this trial is testing

Autonomic Dysfunction in Temporal Lobe Epilepsy and SUDEP

Who this might be right for
Temporal Lobe Epilepsy
Cairo University 54
Testing effectiveness (Phase 2)UnknownNCT03741101
What this trial is testing

Treatment of NF1-related Plexiform Neurofibroma With Trametinib

Who this might be right for
Neurofibromatosis 1ChildNeurofibroma, Plexiform
Region Skane 15
Load More Results